Next Article in Journal
Collateral Victims of Defensive Medical Practice
Previous Article in Journal
Translation, Cultural Adaptation, and Psychometric Evaluation of the Brazilian Portuguese Version of the Quality in Psychiatric Care—Outpatients Instrument
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Effect of Prior Mental Health on Persistent Physical Symptoms after Exposure to a Chemical Disaster

1
Department of Occupational and Environmental Medicine, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea
2
Affiliated Clinic, LG Energy Solution, Cheongju 28122, Republic of Korea
3
Department of Preventive Medicine and Genomic Cohort Institute, Yonsei University Wonju College of Medicine, Wonju 26426, Republic of Korea
*
Author to whom correspondence should be addressed.
Healthcare 2023, 11(7), 1004; https://doi.org/10.3390/healthcare11071004
Submission received: 22 February 2023 / Revised: 29 March 2023 / Accepted: 30 March 2023 / Published: 31 March 2023

Abstract

:
A styrene monomer (SM) oil vapor leak occurred at a chemical plant in Seosan, South Korea on 17 May 2019. A bad odor developed, and many residents complained of various symptoms and visited nearby medical institutions. We analyzed the demographic and clinical characteristics of patients treated at local hospitals and clinics for symptoms related to SM exposure, and identified factors affecting symptom persistence in any organ. Data were collected by the main Seosan office, and 1201 (33.0%) subjects agreed to participate in this study. We used the Assessment of Chemical Exposure toolkit of the Agency for Toxic Substances and Disease Registry. Logistic regression was performed to determine whether mental health symptoms prior to the accident were risk factors for symptom persistence. The strongest risk factor for persistence of at least one symptom in any organ was a preexisting mental health symptom (odds ratio [OR] = 5.47, 95% confidence interval [CI]: 2.57–11.65). Persistent symptoms of the nervous (OR = 1.54), musculoskeletal (OR = 1.92), and gastrointestinal (OR = 1.45) systems were observed. Prior mental health symptoms are risk factors for persistent physical symptoms after a chemical disaster. After a disaster, management of individuals with preaccident mental symptoms or disease is needed.

1. Introduction

The National Institute of Chemical Safety reported that 677 chemical accidents occurred from 2014 to 2021 in South Korea: 31 workers died and 606 were injured [1]. Furthermore, 10 local residents died and 206 were injured. Thus, about 25% of all casualties affected residents. However, most residents recovered without any problems other than acute skin irritation. In South Korea, a health impact investigation (HII) is conducted when even one resident is admitted to hospital because of events including a chemical accident [2].
A styrene monomer (SM) oil vapor leak occurred at a chemical plant in Seosan (city) at 11:45 a.m. on 17 May 2019, and a second leak occurred at 03:40 a.m. on 18 May 2019. About 74.7 tons of SM leaked [1]. The government investigation team found that the company failed to follow due safety procedures in transfer of SM, while skilled employees in charge of handling SM walked out and were replaced by inexperienced substitute workers at the time of the leak. The maximum diffusion range indicated by the Areal Locations of Hazardous Atmospheres (ALOHA) model [3,4,5] was about 2.8 km (Figure 1). Two hours after the first leak, the monomer air concentration in the plant was 36 ppm, and the level became undetectable after 5 h. No SM was detected in a nearby village 5 h after the first exposure. The United States Environmental Protection Agency (EPA) Acute Exposure Guideline Level (AEGL) was level 1: “Notable discomfort, irritation, or certain asymptomatic non-sensory effects” [6,7,8,9,10]. Acute inhalation of >50 ppm of styrene (AEGL-2) may irritate the nasal mucosa and eyes; a level > 100 ppm may cause skin irritation and central nervous system symptoms [11]. Given the SM atmospheric concentrations at Seosan, the only expected symptom was irritation [6]. As this was a short-term, low-concentration exposure, no resident was poisoned or died. However, a bad odor developed, and many residents complained of various symptoms and over 3600 visited nearby medical institutions.
Literature data on similar domestic or foreign SM accidents are lacking. This HII study was conducted as part of an epidemiological investigation mandated by the Enforcement Decree of the Chemical Substance Act. We assessed the health effects and symptoms of SM exposure and factors affecting symptom persistence. Mental health is known to affect vulnerable populations after disasters. A health impact survey conducted after the Horse River wildfire in Alberta, Canada reported that adolescents who had experienced previous trauma and mothers who were pregnant or postpartum had higher rates of mental illness following the disaster [12,13,14,15]. Therefore, we assessed whether residents with previous poor mental health were more adversely affected when exposed to a chemical disaster.

2. Materials and Methods

Up to 25 July 2019, over 3600 residents of Daesan in Seosan visited medical institutions because of SM exposure. Data were collected by the main Seosan office. In October 2019, a temporary health survey center was established in Daesan, and the research team contacted residents who visited the hospital and asked them to visit the survey center. A total of 1201 subjects (33.0%) agreed to participate in this study. Daesan had a population of 14,378 in 2019, so the participation rate was thus 8.4%. The survey ran from October to December 2019, 6 months after the accident.
The Assessment of Chemical Exposure (ACE) toolkit of the Agency for Toxic Substances and Disease Registry (ATSDR) was used in this study [16]. The kit has five modules: exposure location and situation, health status, fire/explosion status, medical treatment, and occupational history. The first module explores the respiration status of the subject at the time of the leak, types of confined space, the strength of any odor, any efforts to move away from the area, and decontamination status. The second module explores the status of the nervous system (7 items), musculoskeletal system (6 items), respiratory system (7 items), cardiovascular system (4 items), gastrointestinal system (9 items), skin (7 items), mental health (6 items), urinary system (2 items), eyes (3 items), nose (2 items), and ears (1 item; 54 items in total). Symptoms present before the accident, any worsening thereof, and symptom persistence for 24 h after the accident and to the time of the investigation were recorded. We assessed whether anxiety, excitement, irritability, fatigue, boredom, insomnia, depression, or hallucinations were present before the accident, and if any such symptoms worsened thereafter. Participants who answered yes to both questions were considered to have had mental health problems before the accident. All subjects self-reported their occupations, locations during exposure, and whether or not to evacuate from the exposed location (evacuation status). Informed consent was obtained from all subjects.
Subjects were grouped according to whether they were occupationally exposed to chemicals. Subject location at the time of the leak was classified as <3, 3–5, 5–9, or ≥10 km (Figure 2). The odor intensity was classified as low, mild, medium, or severe, and evacuation status after smelling the odor was noted. The EPA stated that a monomer concentration of 20 ppm corresponded to AEGL-1 status [6,17].
We recorded symptoms by organ within 24 h of exposure and at the time of the survey, as well as subject characteristics (gender, age, preexisting symptoms or disease) and exposure characteristics (distance from the accident site, occupational exposure, evacuation status). We aimed to identify factors affecting symptoms at the time of the HII survey. All data were analyzed using SPSS for Windows software (ver. 25.0; IBM Corp., Armonk, NY, USA). Age, gender, location at the time of the accident, odor intensity, distance from the accident site, and evacuation status were categorized. Logistic regression analysis was performed to determine whether prior physical and mental symptoms were risk factors for symptom development within 24 h of the accident and persistent symptoms. We adjusted for possible confounding (performance and exposure) factors (location at the time of the accident, odor intensity, distance from the accident site, and evacuation status). We constructed two logistic models: one included all organ symptoms before the accident, while the other did not. A significance level (α) < 0.05 was considered to indicate statistical significance.

3. Results

There were 517 males (43.0%) and 632 females (52.6%) in this study. The gender of 52 cases was not recorded (4.3%). The largest age-group was 60–69 years (n = 321; 26.7%), and only three subjects were aged < 10 years. The average distance from the accident site was 6.7 km, with 582 (48.5%) subjects between 5 km and 10 km from the leakage accident site and 241 (20.1%) at least 10 km away. When asked about the presence of an odor, 23 (1.9%) subjects responded that they did not smell an odor (low), 47 (3.9%) reported a mild odor, 141 (11.7%) reported a moderate odor, and 990 (82.4%) reported a severe odor (Table 1).
Of the participants who reported at least one symptom within 24 h of the accident, the nervous system was affected in 1141 (95%), the gastrointestinal system in 1099 (91.5%), the respiratory system in 1012 (84.3%), and the eyes in 984 (81.9%). Nausea was the most common symptom (1036; 86.3%) followed by headache (1032; 85.9%) and dizziness (1012; 84.3%). The nervous system was the most commonly affected system among the 102 participants (8.5%) who reported at least one symptom before the accident. Of the participants, 355 (29.6%) reported at least one symptom before the accident. Six months later, nervous system (n = 580; 48.3%), mental health (n = 508; 42.3%), and eye (n = 476; 39.6%) symptoms were the most common (Table 2).
Table 3 presents the average number of symptoms by organ according to mental health symptoms prior to accident. Of the symptoms that occurred within 24 h, the average number of symptoms was 18 among cases without mental health symptoms before the accident, and 23.46 in cases where such symptoms were present. The mean number of symptoms was 5.39 in those without mental health symptoms at the time of the survey, and 10.63 in the group with mental symptoms. The number of symptoms was highest in those with mental health-related symptoms before the accident.
In the logistic regression analysis, a prior symptom in any organ was the strongest risk factor for symptom persistence at the time of the survey. The logistic model adopted two types: including and excluding past physical symptoms by organs before the accident, because the odds ratios of preaccident symptoms were too great to offset other effects. The strongest risk factor for the persistence of at least one symptom in any organ was any prior mental health symptom (odds ratio [OR] = 5.47, 95% confidence interval [CI]: 2.57–11.65). The presence of mental health symptoms was a risk factor for persistence of symptoms of the nervous system (OR = 1.54), musculoskeletal system (OR = 1.92), and gastrointestinal system (OR = 1.45). In the model that excluded past physical symptoms, mental health symptoms were risk factors for symptom persistence in all organs, except the ears, and the overall risk of symptom persistence was high (Table 4).

4. Discussion

Disasters include natural disasters, large oil and chemical spills, and traffic pileups. Usually, natural disasters end of their own accord, but the long-term effects of chemical spills are unclear [18]. Although many industrial and environmental disasters involving neurotoxins or radioactive contamination have occurred over the last few decades, the effects on psychological function have been little studied [19]. Very few reports have described the acute effects of exposure to SM. Acute inhalation of >50 ppm SM (AEGL-2) irritates the nasal mucosa and eyes. In amounts > 100 ppm, skin irritation and central nervous system problems develop, with the latter including nausea, lethargy, and poor coordination [20,21,22,23]. A very unpleasant odor is present at 0.3 ppm [24], and this is a valuable warning sign. The closest residents were 1.34 km away from the leak area. The Carris and ALOHA atmospheric diffusion models of the first leak (17 May) yielded AEGL-1, -2, and -3 radii of 2.8, 0.97, and 0.33 km, and resident exposure levels were low. Residents were exposed to concentrations below AEGL-1, and the second leak was less serious than the first. At or below the AEGL-1 level, irritation would not be expected [25]. The maximum styrene level was less than AEGL-2, and no AEGL-3 exposure occurred in residential areas. Although significant health effects were thus not expected, many residents complained that their symptoms persisted for up to 6 months after exposure. As a result of identifying the health effects of the SM leakage accident on residents, it is certain that all 1201 people who participated in the health effect survey smelled the smell caused by exposure. In addition, it was determined that it is certain that 1197 people, excluding 4 of them, had mild or moderate irritation symptoms due to the smell.
Acute chemical exposures (such as spills) commonly induce irritation, long-term chronic disease, anxiety, depression, and somatization [26]. Some studies have suggested that preexisting psychiatric factors may play roles in symptom persistence after exposure to major toxins [26]. Chemical spills not only induce physical problems but also mental conditions including posttraumatic embitterment disorder (PTED), major depression, and anxiety. It is difficult to determine whether leaks cause the mental health problems or exacerbate poor existing mental health [27]. Predisaster mental health assessments are not usually available, because it is impossible to predict when a disaster will occur. However, those with prior mental health problems may be more sensitive to new or worsening physical symptoms after an accident. Prior psychological problems are strong predictors of additional difficulties after a disaster [28]. We found that prior physical and mental health symptoms were the strongest predictors of symptom persistence after exposure to SM. Poor mental health status predicts postoperative pain persistence [29]. Depression increases the likelihood of poor outcomes in individuals with nonfatal conditions. Interactions among numerous risk factors may explain problems such as prior major depressive disorder [30]. Our findings are consistent with these results.
Individuals affected by leakages may seek compensation for mental and physical harm, and systemic symptoms are more frequent in those seeking compensation [31,32]. PTED is a reactive disorder induced by negative life events, and associated mental health problems may be highly persistent [33]. Seosan has an industrial complex with many factories (including chemical factories). Residents are chronically exposed to low concentrations of various substances that may affect the central nervous and respiratory systems, as well as the eyes and skin. We suggest that living in such an area is associated with perceived risks to health and safety, which may cause anxiety, insomnia, and depression [34,35]. The chemical disaster at the Cantara Loop of the Sacramento River triggered severe psychological, psychosocial, psychophysiological, and physical reactions in exposed compared to unexposed residents [36]. At the time of investigation (6 months after the leak), affected residents experienced more depression, anxiety, and physical symptoms. The media imprinted and consolidated memories of the disaster: long-term negative media coverage may induce posttraumatic stress-related symptoms. As media attention increased, so too did medically unexplained somatic symptoms [37]. However, we found no literature on the impact of news media on PTED.
This study had both strengths and limitations. As a strength, all residential areas within 10 km of the accident were included, and an exposure assessment was performed. We also recorded symptoms present before and within 24 h of the accident and at the time of the survey (average of 6 months later). Thus, we determined whether existing symptoms were exacerbated or new symptoms developed. Although we assessed psychiatric problems, we did not use a recognized scale (such as the Minnesota Multiphasic Personality Inventory); rather, we used the ACE toolkit, which is designed to evaluate accidents. However, reliability analysis was not performed on the main investigation items, such as the subject’s symptoms. The interview survey used in this study may have introduced several biases. A bias is likely to arise from persons failing to ascertain the onset time for exposure or symptoms [38]. Respondents can optionally hide personal symptoms or medical history information [39]. Some questions may be structured to cause respondents to select incorrect answers [40]. This may be the effect of memory decay bias that occurred after more than 5 months of the health effect survey. In addition, no biomarker or clinical definition of styrene toxicity exists, making it difficult to distinguish the effects of styrene from other effects. Finally, we only explored symptoms, which are somewhat subjective and may not fully reflect SM exposure.

5. Conclusions

In conclusion, prior mental health-related symptoms are risk factors for symptom persistence after chemical disaster. Our study indicates that after a disaster, management of individuals with preaccident mental symptoms or disease is needed. Even if it is not a large-scale disaster, such mental health care is important in chemical accidents that cause a lot of health concerns among residents.

Author Contributions

Conceptualization, Y.-S.M. and Y.-S.A.; methodology, Y.-S.A.; software, Y.-S.A.; validation, Y.-S.A., Y.-S.M. and S.-Y.K.; formal analysis, Y.-S.A.; investigation, S.-K.C. and Y.-S.A.; resources, Y.-S.A.; data curation, S.-K.C. and Y.-S.A.; writing—original draft preparation, Y.-S.M., Y.-S.A. and Y.-S.M.; writing—review and editing, S.-Y.K. and Y.-S.A.; supervision, Y.-S.A., Y.-S.M. and S.-Y.K.; funding acquisition, Y.-S.M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Soonchunhyang University Research Fund.

Institutional Review Board Statement

All protocols were reviewed and approved by the Institutional Review Board (IRB) of Yonsei University Wonju Severance Christian Hospital (IRB CR322342).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. NICS. Statistics. 2019. Available online: https://icis.me.go.kr/search/searchType2.do?menuNo (accessed on 25 November 2022).
  2. Ministry of Environment. Enforcement Decree of the Chemical Substances Control Act (Article 18); Ministry of Environment: Sejong-si, Republic of Korea, 2021.
  3. Inanloo, B.; Tansel, B. Explosion impacts during transport of hazardous cargo: GIS-based characterization of overpressure impacts and delineation of flammable zones for ammonia. J. Env. Manag. 2015, 156, 1–9. [Google Scholar] [CrossRef] [PubMed]
  4. Fatemi, F.; Ardalan, A.; Aguirre, B.; Mansouri, N.; Mohammadfam, I. Areal location of hazardous atmospheres simulation on toxic chemical release: A scenario-based case study from Ray, Iran. Electron. Physician 2017, 9, 5638–5645. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Shojaee Barjoee, S.; Dashtian, A.H.; Keykhosravi, S.S.; Abbasi Saryazdi, M.J.; Afrough, M.J. Modeling the environmental, health, and safety aspects of xylene isomer emission from storage tanks in petrochemical industries, Iran. Env. Monit. Assess. 2021, 193, 783. [Google Scholar] [CrossRef] [PubMed]
  6. Environmental Protection Agency. Styrene Interim AEGL Document; USA Environmental Protection Agency: Washington, DC, USA, 2008.
  7. Griffiths, S.D.; Entwistle, J.A.; Kelly, F.J.; Deary, M.E. Characterising the ground level concentrations of harmful organic and inorganic substances released during major industrial fires, and implications for human health. Env. Int. 2022, 162, 107152. [Google Scholar] [CrossRef] [PubMed]
  8. Meier, D.C.; Benkstein, K.D.; Hurst, W.S.; Chu, P.M. Fourier Transform Infrared Absorption Spectroscopy for Quantitative Analysis of Gas Mixtures at Low Temperatures for Homeland Security Applications. J. Test. Eval. 2017, 45, 922–932. [Google Scholar] [CrossRef] [Green Version]
  9. Stage, S.A. Determination of acute exposure guideline levels in a dispersion model. J. Air Waste Manag. Assoc. 2004, 54, 49–59. [Google Scholar] [CrossRef] [Green Version]
  10. Mielke, H.; Gundert, A.; Abraham, K.; Gundert-Remy, U. Acute inhalative exposure assessment: Derivation of guideline levels with special regard to sensitive subpopulations and time scaling. Toxicology 2005, 214, 256–267. [Google Scholar] [CrossRef]
  11. Dalton, P.; Lees, P.S.; Gould, M.; Dilks, D.; Stefaniak, A.; Bader, M.; Ihrig, A.; Triebig, G. Evaluation of long-term occupational exposure to styrene vapor on olfactory function. Chem. Senses 2007, 32, 739–747. [Google Scholar] [CrossRef] [Green Version]
  12. Hyde, A.; Verstraeten, B.S.E.; Olson, J.K.; King, S.; Brémault-Phillips, S.; Olson, D.M. The Fort McMurray Mommy Baby Study: A Protocol to Reduce Maternal Stress Due to the 2016 Fort McMurray Wood Buffalo, Alberta, Canada Wildfire. Front. Public. Health 2021, 9, 601375. [Google Scholar] [CrossRef]
  13. Brown, M.R.G.; Pazderka, H.; Agyapong, V.I.O.; Greenshaw, A.J.; Cribben, I.; Brett-MacLean, P.; Drolet, J.; McDonald-Harker, C.B.; Omeje, J.; Lee, B.; et al. Mental Health Symptoms Unexpectedly Increased in Students Aged 11-19 Years During the 3.5 Years After the 2016 Fort McMurray Wildfire: Findings From 9,376 Survey Responses. Front. Psychiatry 2021, 12, 676256. [Google Scholar] [CrossRef]
  14. Fitzpatrick, K.M.; Wild, T.C.; Pritchard, C.; Azimi, T.; McGee, T.; Sperber, J.; Albert, L.; Montesanti, S. Health Systems Responsiveness in Addressing Indigenous Residents’ Health and Mental Health Needs Following the 2016 Horse River Wildfire in Northern Alberta, Canada: Perspectives from Health Service Providers. Front. Public. Health 2021, 9, 723613. [Google Scholar] [CrossRef] [PubMed]
  15. Pazderka, H.; Brown, M.R.G.; Agyapong, V.I.O.; Greenshaw, A.J.; McDonald-Harker, C.B.; Noble, S.; Mankowski, M.; Lee, B.; Drolet, J.L.; Omeje, J.; et al. Collective Trauma and Mental Health in Adolescents: A Retrospective Cohort Study of the Effects of Retraumatization. Front. Psychiatry 2021, 12, 682041. [Google Scholar] [CrossRef]
  16. Duncan, M.A.; Orr, M.F. Toolkit for Epidemiologic Response to an Acute Chemical Release. Disaster Med. Public. Health Prep. 2016, 10, 631–632. [Google Scholar] [CrossRef] [PubMed]
  17. Committee on Acute Exposure Guideline Levels; Committee on Toxicology; Board on Environmental Studies and Toxicology; Division on Earth and Life Studies; National Academies of Sciences. Acute Exposure Guideline Levels for Selected Airborne Chemicals; National Academies Press: Washington, DC, USA, 2016; pp. 6–9. [Google Scholar]
  18. Na, J.Y.; Woo, K.H.; Yoon, S.Y.; Cho, S.Y.; Song, I.U.; Kim, J.A.; Kim, J.S. Acute symptoms after a community hydrogen fluoride spill. Ann. Occup. Env. Med. 2013, 25, 17. [Google Scholar] [CrossRef] [Green Version]
  19. Arnedo-Pena, A.; Bellido-Blasco, J.; Villamarin-Vazquez, J.L.; Aranda-Mares, J.L.; Font-Cardona, N.; Gobba, F.; Kogevinas, M. Acute health effects after accidental exposure to styrene from drinking water in Spain. Env. Health 2003, 2, 6. [Google Scholar] [CrossRef] [Green Version]
  20. NTP. Styrene. Rep. Carcinog. 2011, 12, 383–391. [Google Scholar]
  21. Meyer, K.C.; Sharma, B.; Kaufmann, B.; Kupper, A.; Hodgson, M. Lung disease associated with occupational styrene exposure. Am. J. Ind. Med. 2018, 61, 773–779. [Google Scholar] [CrossRef]
  22. Edling, C.; Anundi, H.; Johanson, G.; Nilsson, K. Increase in neuropsychiatric symptoms after occupational exposure to low levels of styrene. Br. J. Ind. Med. 1993, 50, 843–850. [Google Scholar] [CrossRef] [Green Version]
  23. Triebig, G.; Lehrl, S.; Weltle, D.; Schaller, K.H.; Valentin, H. Clinical and neurobehavioural study of the acute and chronic neurotoxicity of styrene. Br. J. Ind. Med. 1989, 46, 799–804. [Google Scholar] [CrossRef] [Green Version]
  24. Lees-Haley, P.R.; Brown, R.S. Biases in perception and reporting following a perceived toxic exposure. Percept. Mot. Ski. 1992, 75, 531–544. [Google Scholar] [CrossRef]
  25. Ministry of Environment. Accident of Hanwha Total’s Chemical Leakage [May 17th–18th, 2019] Final Report on Joint Investigation with Related Organizations; Ministry of Environment: Sejong-si, Republic of Korea, 2019.
  26. Greve, K.W.; Bianchini, K.J.; Doane, B.M.; Love, J.M.; Stickle, T.R. Psychological evaluation of the emotional effects of a community toxic exposure. J. Occup. Env. Med. 2005, 47, 51–59. [Google Scholar] [CrossRef] [PubMed]
  27. Galea, S.; Maxwell, A.R.; Norris, F. Sampling and design challenges in studying the mental health consequences of disasters. Int. J. Methods Psychiatr. Res. 2008, 17 (Suppl. S2), S21–S28. [Google Scholar] [CrossRef] [PubMed]
  28. Norris, F.H. Disasters in urban context. J. Urban. Health 2002, 79, 308–314. [Google Scholar] [CrossRef] [Green Version]
  29. Lewis, G.N.; Rice, D.A.; McNair, P.J.; Kluger, M. Predictors of persistent pain after total knee arthroplasty: A systematic review and meta-analysis. Br. J. Anaesth. 2015, 114, 551–561. [Google Scholar] [CrossRef] [Green Version]
  30. Chiriţă, A.L.; Gheorman, V.; Bondari, D.; Rogoveanu, I. Current understanding of the neurobiology of major depressive disorder. Rom. J. Morphol. Embryol. 2015, 56, 651–658. [Google Scholar]
  31. Lees, P.S.; Stefaniak, A.; Emmett, E.A.; Dalton, P. Exposure assessment for study of olfactory function in workers exposed to styrene in the reinforced-plastics industry. Am. J. Ind. Med. 2003, 44, 12–23. [Google Scholar] [CrossRef] [PubMed]
  32. Linden, M. Querulant delusion and post-traumatic embitterment disorder. Int. Rev. Psychiatry 2020, 32, 396–402. [Google Scholar] [CrossRef]
  33. Linden, M.; Baumann, K.; Rotter, M.; Schippan, B. Diagnostic criteria and the standardized diagnostic interview for posttraumatic embitterment disorder (PTED). Int. J. Psychiatry Clin. Pr. 2008, 12, 93–96. [Google Scholar] [CrossRef] [PubMed]
  34. Rivière, S.; Albessard, A.; Gardette, V.; Lapierre-Duval, K.; Schwoebel, V.; Lang, T. Psychosocial risk factors for depressive symptoms after the AZF chemical factory explosion in Toulouse, France. Eur. J. Public. Health 2010, 20, 625–630. [Google Scholar] [CrossRef] [Green Version]
  35. Racette, B.A.; Nelson, G.; Dlamini, W.W.; Hershey, T.; Prathibha, P.; Turner, J.R.; Checkoway, H.; Sheppard, L.; Searles Nielsen, S. Depression and anxiety in a manganese-exposed community. Neurotoxicology 2021, 85, 222–233. [Google Scholar] [CrossRef]
  36. Bowler, R.M.; Mergler, D.; Huel, G.; Cone, J.E. Psychological, psychosocial, and psychophysiological sequelae in a community affected by a railroad chemical disaster. J. Trauma. Stress. 1994, 7, 601–624. [Google Scholar] [CrossRef] [PubMed]
  37. Yzermans, C.J.; Donker, G.A.; Kerssens, J.J.; Dirkzwager, A.J.; Soeteman, R.J.; ten Veen, P.M. Health problems of victims before and after disaster: A longitudinal study in general practice. Int. J. Epidemiol. 2005, 34, 820–826. [Google Scholar] [CrossRef]
  38. Choi, B.C.; Pak, A.W. A catalog of biases in questionnaires. Prev. Chronic Dis. 2005, 2, A13. [Google Scholar] [PubMed]
  39. Fennema, J.S.; van Ameijden, E.J.; Coutinho, R.A.; van den Hoek, J.A. Validity of self-reported sexually transmitted diseases in a cohort of drug-using prostitutes in Amsterdam: Trends from 1986 to 1992. Int. J. Epidemiol. 1995, 24, 1034–1041. [Google Scholar] [CrossRef] [PubMed]
  40. Sackett, D.L. Bias in analytic research. J. Chronic Dis. 1979, 32, 51–63. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Area affected by the styrene monomer leakage.
Figure 1. Area affected by the styrene monomer leakage.
Healthcare 11 01004 g001
Figure 2. Geocoded locations of study participants at the time of exposure (blue spot). The spill area is indicated by the red spot.
Figure 2. Geocoded locations of study participants at the time of exposure (blue spot). The spill area is indicated by the red spot.
Healthcare 11 01004 g002
Table 1. Characteristics of study subjects.
Table 1. Characteristics of study subjects.
MenWomenUnknownTotal
Number
(Person)
Proportion (%)Number
(Person)
Proportion (%)Number
(Person)
Proportion (%)Number
(Person)
Proportion
(%)
Age<2981.681.200161.3
30–39234.4152.400383.2
40–49489.3436.800917.6
50–591242413120.70025521.2
60–6913726.518228.823.832126.7
≥7017734.225340.30043035.8
Unknown00005096.2504.2
JobNo24647.641966.3 *3669.270158.4
Yes (No chemical exposure)22844.1177281223.141734.7
Yes (Chemical exposure)438.3365.747.7836.9
Distance from accident site<3 km14928.88813.9611.524320.2
3–4.99 km6412.46910.923.813511.2
5–9.99 km22443.332952.12955.858248.5
≥10 km8015.514623.11528.824120.1
Location at the time of the accident In door11422.119330.51732.732427
Out door40377.9 *43969.53567.387773
Odor intensityLow91.7111.735.8231.9
Mild234.4213.335.8473.9
Moderate6913.36610.4611.514111.7
Severe41680.553484.54076.999082.4
Evacuation statusNo3106041565.73771.276263.4
Yes2074021734.31528.843936.6
* p < 0.05 by chi-squared test.
Table 2. Symptom prevalence by organ and time point.
Table 2. Symptom prevalence by organ and time point.
SymptomsExperienced Symptom within 24 h of the IncidentExperienced Symptom before the IncidentSymptom Worse after the IncidentStill Experiencing Symptom
Prevalence%Prevalence%Prevalence%Prevalence%
Nervous systemHeadache103285.9 373.1 18115.141934.9
Dizziness101284.3 403.3 17914.941334.4
Seizures80.7 10.1 40.380.7
Numbness pins and needles42935.7 413.4 1018.424420.3
Difficulty concentrating54845.6 90.7 615.114812.3
Confusion34428.6 20.2 151.2625.2
Loss of balance33527.9 110.9 231.9715.9
Subtotal114195.0 1028.5 27122.658048.3
RespiratoryBreathing slow1109.2 40.3 50.4252.1
Breathing fast46238.5 100.8 221.8675.6
Difficulty breathing/feeling out-of-breath67856.5 201.7 756.319516.2
Coughing83769.7 242.0 1159.630825.6
Increased congestion or phlegm65454.5242.0 12710.627923.2
Wheezing in chest46939.1110.9 322.71189.8
Subtotal101284.3756.2 20216.845738.1
MusculoskeletalWeakness of arms 48540.4 242.0 766.319015.8
Weakness of legs 48940.7 282.3 776.418315.2
Muscle twitching 23819.8 90.7 282.3907.5
Tremors in arms or legs35829.8 121.0 554.612710.6
Generalized weakness36930.7 90.7 423.515312.7
Diffuse muscle aches and pains38231.8221.8 907.518815.7
Subtotal73160.9715.9 17114.237631.3
CardiovascularSlow heart rate/pulse 645.3 60.5 40.3231.9
Fast heart rate/pulse 39232.6 50.4 141.2514.2
Chest tightness or pain/angina52143.4 141.2 877.220517.1
Blue or gray coloring of ends of fingers/toes or lips665.5 40.3 70.6231.9
Subtotal64954.0 252.1 988.223719.7
GastrointestinalNausea 103686.3 161.3 12110.127823.1
Vomiting39532.9 60.5 383.2635.2
Diarrhea18815.7 60.5 201.7443.7
Abdominal pain31626.3 70.6 211.7655.4
Subtotal109991.5 645.1 20517.140934.1
SkinIrritation, pain, or burning of skin46038.3 70.6 675.618015
Skin rash23919.9 50.4 423.51078.9
Skin blisters998.2 50.4 201.7373.1
Sweating 44937.4 191.6 312.6594.9
Cool or pale skin23119.2 40.3 80.7322.7
Skin discoloration937.750.4 141.2292.4
Subtotal70558.7403.3 1018.426422
Mental healthAnxiety74261.8 242.0 1089.032026.6
Agitation/irritability60150.0 90.7 736.120417
Fatigue/tiredness73361.0 211.7 1109.227122.6
Difficulty sleeping71259.3 272.2 15613.033628
Feeling depressed46839.0 100.8 786.520617.2
Hallucinations645.3 10.1 40.3161.3
Subtotal92376.9 705.8 21618.050842.3
EyeIrritation/pain/burning85170.9 433.6 14311.934428.6
Increased tearing74962.4 373.1 1159.628123.4
Blurred vision67456.1 463.8 15512.931826.5
Subtotal98481.9 897.4 22919.147639.6
Total119799.7 35529.6 53644.685371
Table 3. Average number of symptoms by organ in subjects with mental health symptoms before the accident.
Table 3. Average number of symptoms by organ in subjects with mental health symptoms before the accident.
Organ SystemsInvestigation PeriodMental Health Symptoms Prior to Accident
NoYesp-Value
Nerve systemWithin 24-h of the accident3.02 3.37 0.002
Six months after accident 0.99 1.71 0.000
MusculoskeletalWithin 24-hof the accident1.75 2.66 0.000
Six months after accident 0.60 1.48 0.000
RespiratoryWithin 24-hof the accident2.75 3.51 0.000
Six months after accident 0.79 1.25 0.000
CardiovascularWithin 24-h of the accident0.80 1.13 0.000
Six months after accident 0.22 0.37 0.000
GastrointestinalWithin 24-h of the accident2.37 3.13 0.000
Six months after accident 0.49 0.93 0.000
SkinWithin 24-h of the accident1.23 1.63 0.000
Six months after accident 0.33 0.53 0.001
Mental healthWithin 24-h of the accident2.56 3.59 0.000
Six months after accident 0.83 2.32 0.000
GenitourinaryWithin 24-h of the accident0.24 0.55 0.000
Six months after accident 0.11 0.45 0.000
EyeWithin 24-h of the accident1.83 2.13 0.000
Six months after accident 0.70 1.12 0.000
NoseWithin 24-h of the accident1.10 1.30 0.000
Six months after accident 0.23 0.34 0.000
TotalWithin 24-h of the accident18.02 23.46 0.000
Six months after accident 5.39 10.63 0.000
Table 4. Preexisting mental health symptoms affecting symptom persistence at the time of investigation.
Table 4. Preexisting mental health symptoms affecting symptom persistence at the time of investigation.
Organ SystemsAdjusted for Preexisting Physical Symptoms *Unadjusted for Preexisting Physical Symptoms *
Odds Ratio
95% C.I.
Nagelkerke R2Hosmer and Lemeshow TestOdds Ratio
95% C.I.
Nagelkerke R2Hosmer and Lemeshow Test
Nervous system1.54 (1.08–2.20)0.1800.1133.17 (2.33–4.33)0.2260.245
Musculoskeletal1.92 (1.32–2.79)0.2060.1724.95 (3.65–6.71)0.2640.146
Respiratory1.04 (0.71–1.51)0.1910.3762.70 (2.02–3.62)0.1430.781
Cardiovascular0.78 (0.49–1.22)0.1500.4082.19 (1.58–3.03)0.1330.269
Gastrointestinal1.45 (1.02–2.05)0.1530.4543.01 (2.25–4.04)0.1340.130
Skin0.82 (0.54–1.23)0.1560.4851.84 (1.34–2.54)0.1260.519
Urogenital1.21 (0.70–2.08)0.2370.4194.04 (2.80–5.82)0.1450.178
Eye0.98 (0.68–1.41)0.1970.7072.26 (1.69–3.02)0.1480.352
Nose0.95 (0.63–1.43)0.1490.7981.85 (1.33–2.58)0.1340.505
Ear0.49 (0.27–0.90)0.1200.2211.22 (0.78–1.89)0.1180.694
Total5.47 (2.57–11.65)0.2410.12515.29 (7.45–31.36)0.1930.114
* Adjusted for sex, location at the time of the accident, odor intensity, distance from accident site, evacuation status, and age.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Min, Y.-S.; Kim, S.-Y.; Choi, S.-K.; Ahn, Y.-S. The Effect of Prior Mental Health on Persistent Physical Symptoms after Exposure to a Chemical Disaster. Healthcare 2023, 11, 1004. https://doi.org/10.3390/healthcare11071004

AMA Style

Min Y-S, Kim S-Y, Choi S-K, Ahn Y-S. The Effect of Prior Mental Health on Persistent Physical Symptoms after Exposure to a Chemical Disaster. Healthcare. 2023; 11(7):1004. https://doi.org/10.3390/healthcare11071004

Chicago/Turabian Style

Min, Young-Sun, Soo-Young Kim, Sun-Kyeong Choi, and Yeon-Soon Ahn. 2023. "The Effect of Prior Mental Health on Persistent Physical Symptoms after Exposure to a Chemical Disaster" Healthcare 11, no. 7: 1004. https://doi.org/10.3390/healthcare11071004

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop